Scientific Advisory Board

The iReceptor Plus Scientific Advisory Board is comprises prominent scientists and researchers in the fields of immunology and genetics.

The Scientific Advisory Board is responsible for reviewing and helping guide the scientific excellence of iReceptor Plus project research and to review proposed research projects for scientific excellence and recommend new avenues for research investment (novel research gaps, opportunities and so on) to the project’s Executive.

The members of the iReceptor Plus Scientific Advisory Board are:

Prof. Gunilla Karlsson Hedestam

Prof. Karlsson Hedestam of the Karolinska Institutet in Stockholm, Sweden conducts research in the field of immunology and immunogenetics, with a special focus on B cells.

She is a member of the Department management board since 2009 and the Deputy Head of the Department of Microbiology, Tumor and Cell Biology since 2013. She was elected to the Nobel Assembly at Karolinska Institutet in 2016 and as of 2019, she is a member of the Nobel Committee for the Prize in Medicine or Physiology.

Prof. Steven H. Kleinstein

Prof. Kleinstein of the School of Medicine at Yale University in New Haven, Connecticut is a computational immunologist with a combination of “big data” analysis and immunology domain expertise.

He is currently a professor in the Department of Pathology and Department of Immunobiology at the Yale School of Medicine and a member of the Human and Translational Immunology program, the Yale Center for Medical Informatics and the Interdepartmental Program for Computational Biology and Bioinformatics. He received a B.A.S. in Computer Science from the University of Pennsylvania and a Ph.D. in Computer Science from Princeton University.

Prof. Felix Breden

Prof. Breden, who is Scientific Director of the iReceptor Plus Consortium, is Professor Emeritus at the Department of Biological Sciences at the Simon Fraser University in British Columbia, Canada.

He is an expert in the field of population genetics and genomics researching how complex biological interactions control the divergence of genes, individuals and populations. Prof. Breden, who is one of the founders and an active member of the AIRR Community, received a Ph.D. from the University of Chicago.